Times survival analysis. Medical search. Frequent questions

Home page Questions and answers Statistics Donations Contact

Anatomy4

Cell Line, Tumor Bile Ducts, Intrahepatic Lymph Nodes Cells, Cultured

Organisms3

Strongylida Mice, Inbred C57BL Mice, Knockout

Diseases61

Breast Neoplasms Neoplasm Recurrence, Local Disease Progression Lung Neoplasms Lymphatic Metastasis Adenocarcinoma Recurrence Liver Neoplasms Brain Neoplasms Prosthesis Failure Carcinoma, Squamous Cell Carcinoma Colorectal Neoplasms Neoplasm Metastasis Stomach Neoplasms Neoplasm Invasiveness Ovarian Neoplasms Carcinoma, Non-Small-Cell Lung Neoplasms Carcinoma, Hepatocellular Glioblastoma Kidney Failure, Chronic Melanoma Esophageal Neoplasms Postoperative Complications Pancreatic Neoplasms Cholangiocarcinoma Rectal Neoplasms Bone Neoplasms Skin Neoplasms Kidney Neoplasms Prostatic Neoplasms Glioma Nasopharyngeal Neoplasms Bile Duct Neoplasms Carcinoma, Renal Cell Inhalant Abuse Head and Neck Neoplasms Osteosarcoma Astrocytoma Sarcoma Colonic Neoplasms HIV Infections Urinary Bladder Neoplasms Multiple Myeloma Carcinoma, Ductal, Breast Endometrial Neoplasms Lymphoma, Large B-Cell, Diffuse Mouth Neoplasms Carcinoma, Transitional Cell Heart Failure Lymphoma, Non-Hodgkin Chronic Disease Oligodendroglioma Tongue Neoplasms Disease Models, Animal Genetic Predisposition to Disease Acquired Immunodeficiency Syndrome Carcinoma, Small Cell Stroke Cystadenocarcinoma, Serous

Chemicals and Drugs26

Tumor Markers, Biological Antineoplastic Agents Ki-67 Antigen Cisplatin Cyclophosphamide Fluorouracil Receptor, erbB-2 Tumor Suppressor Protein p53 Neoplasm Proteins Doxorubicin Receptors, Estrogen Receptors, Progesterone Biological Markers Prednisone RNA, Messenger Vincristine Proto-Oncogene Proteins Antibodies, Monoclonal Tumor Suppressor Proteins Immunosuppressive Agents Survival of Motor Neuron 1 Protein Antineoplastic Agents, Hormonal Receptor, Epidermal Growth Factor alpha-Fetoproteins DNA, Neoplasm Nuclear Proteins

Analytical, Diagnostic and Therapeutic Techniques and Equipment105

Survival Analysis Survival Rate Kaplan-Meier Estimate Disease-Free Survival Prognosis Proportional Hazards Models Retrospective Studies Treatment Outcome Follow-Up Studies Neoplasm Staging Multivariate Analysis Risk Factors Cohort Studies Prospective Studies Immunohistochemistry Predictive Value of Tests Registries Life Tables Combined Modality Therapy Antineoplastic Combined Chemotherapy Protocols Risk Assessment Incidence Tissue Array Analysis Chemotherapy, Adjuvant Prosthesis Failure Neoplasm Grading Regression Analysis Reoperation Longitudinal Studies Models, Statistical SEER Program Biostatistics Cause of Death Analysis of Variance Chi-Square Distribution Probability Radiotherapy, Adjuvant Gene Expression Profiling Risk Severity of Illness Index Actuarial Analysis Mortality Kidney Transplantation Cementation Neoadjuvant Therapy Hip Prosthesis Immunoenzyme Techniques Treatment Failure Drug Administration Schedule Reverse Transcriptase Polymerase Chain Reaction Data Interpretation, Statistical Tumor Burden Remission Induction Statistics, Nonparametric Logistic Models Oligonucleotide Array Sequence Analysis Prosthesis Design Renal Dialysis Liver Transplantation ROC Curve Breeding Transplantation, Homologous Case-Control Studies Reproducibility of Results Mitotic Index Randomized Controlled Trials as Topic Life Expectancy Patient Selection Chemoradiotherapy Blotting, Western Confidence Intervals Epidemiologic Methods Hepatectomy Clinical Trials as Topic Chemoembolization, Therapeutic Drug Therapy, Combination Knee Prosthesis Statistical Distributions Lymph Node Excision Models, Biological Palliative Care Odds Ratio Arthroplasty, Replacement, Hip Multicenter Studies as Topic Heart Transplantation Sensitivity and Specificity Endpoint Determination Gastrectomy Esophagectomy Linear Models Cluster Analysis Cystectomy Radiotherapy Biometry CD4 Lymphocyte Count Polymerase Chain Reaction Joint Prosthesis Prevalence Pneumonectomy Disease Models, Animal Limb Salvage Peritoneal Dialysis Propensity Score Mastectomy Hospital Mortality

Psychiatry and Psychology3

Cannibalism Inhalant Abuse Smoking

Phenomena and Processes31

Cell Survival Time Factors Graft Survival Gene Expression Regulation, Neoplastic Apoptosis Longevity Chi-Square Distribution Probability Risk Signal Transduction Mutation Cell Proliferation Graft Rejection Breeding Genotype Statistical Distributions Odds Ratio Pregnancy Dose-Response Relationship, Drug Sensitivity and Specificity Up-Regulation Algorithms Vascular Patency Phenotype CD4 Lymphocyte Count Polymorphism, Single Nucleotide Drug Resistance, Neoplasm Gene Expression Genetic Predisposition to Disease Cell Division Microbial Viability

Disciplines and Occupations2

Immunohistochemistry Outcome Assessment (Health Care)

Anthropology, Education, Sociology and Social Phenomena5

Survival Age Distribution Socioeconomic Factors Quality of Life Sex Distribution

Humanities1

Quality of Life

Information Science13

Survival Rate Registries Life Tables Incidence SEER Program Cause of Death Mortality Databases, Factual Data Interpretation, Statistical Life Expectancy Algorithms Prevalence Hospital Mortality

Named Groups4

Infant, Newborn Patient Dropouts Survivors European Continental Ancestry Group

Health Care62

Survival Analysis Survival Rate Kaplan-Meier Estimate Disease-Free Survival Proportional Hazards Models Retrospective Studies Treatment Outcome Follow-Up Studies Multivariate Analysis Risk Factors Cohort Studies Prospective Studies Predictive Value of Tests Age Factors Registries Life Tables Risk Assessment Incidence Regression Analysis Longitudinal Studies Sex Factors Models, Statistical SEER Program Cause of Death Analysis of Variance Chi-Square Distribution Probability Age of Onset Risk Severity of Illness Index Actuarial Analysis Mortality Comorbidity Treatment Failure Data Interpretation, Statistical Statistics, Nonparametric Logistic Models ROC Curve Case-Control Studies Reproducibility of Results Randomized Controlled Trials as Topic Life Expectancy Patient Selection Bias (Epidemiology)Confidence Intervals Epidemiologic Methods Clinical Trials as Topic Statistical Distributions Age Distribution Palliative Care Odds Ratio Multicenter Studies as Topic Sensitivity and Specificity Outcome Assessment (Health Care)Linear Models Cluster Analysis Biometry Socioeconomic Factors Prevalence Sex Distribution Propensity Score Hospital Mortality

Geographicals14

United States Macau France Europe Spain Italy Sweden China Denmark Japan Iran Taiwan Netherlands Australia

Anatomy Organisms Diseases Chemicals and Drugs Analytical, Diagnostic and Therapeutic Techniques and Equipment Psychiatry and Psychology Phenomena and Processes Disciplines and Occupations Anthropology, Education, Sociology and Social Phenomena Information Science Named Groups Health Care Geographicals

Survival Analysis Survival Rate Cell Survival Kaplan-Meier Estimate Disease-Free Survival Prognosis Proportional Hazards Models Survival Retrospective Studies Treatment Outcome Follow-Up Studies Time Factors Neoplasm Staging Graft Survival Multivariate Analysis Risk Factors Cohort Studies Tumor Markers, Biological Prospective Studies Immunohistochemistry Breast Neoplasms Predictive Value of Tests Age Factors Neoplasm Recurrence, Local Registries Life Tables Disease Progression Lung Neoplasms Lymphatic Metastasis Combined Modality Therapy Adenocarcinoma Antineoplastic Combined Chemotherapy Protocols Recurrence Risk Assessment Incidence Tissue Array Analysis Liver Neoplasms Brain Neoplasms Chemotherapy, Adjuvant Prosthesis Failure Carcinoma, Squamous Cell Carcinoma Neoplasm Grading Colorectal Neoplasms Neoplasm Metastasis Gene Expression Regulation, Neoplastic Regression Analysis Apoptosis Reoperation Antineoplastic Agents Stomach Neoplasms Neoplasm Invasiveness Longitudinal Studies Ovarian Neoplasms Carcinoma, Non-Small-Cell Lung Sex Factors Models, Statistical United States SEER Program Biostatistics Neoplasms Longevity Cause of Death Cell Line, Tumor Analysis of Variance Chi-Square Distribution Probability Carcinoma, Hepatocellular Ki-67 Antigen Glioblastoma Radiotherapy, Adjuvant Age of Onset Kidney Failure, Chronic Gene Expression Profiling Risk Melanoma Severity of Illness Index Actuarial Analysis Cannibalism Signal Transduction Esophageal Neoplasms Postoperative Complications Mortality Mutation Strongylida Cell Proliferation Cisplatin Pancreatic Neoplasms Kidney Transplantation Cementation Neoadjuvant Therapy Cyclophosphamide Comorbidity Hip Prosthesis Fluorouracil Immunoenzyme Techniques Receptor, erbB-2 Treatment Failure Tumor Suppressor Protein p53 Drug Administration Schedule

No FAQ available that match "times survival analysis"